Find a TenderClosedTender notice
Published 29 Apr 2026, 12:21 BST

Official UK procurement notice

BCG Vaccine & TB Skin Test (2027)

Official notice

Authority: Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency (Central government)

2 lotsGoodsCompetitive flexible procedureAbove threshold
Sectors: Medical Devices & Pharma (33) Delivery: UK
Budget not disclosed£0total for 2 lots
Submissions closed 15 Jun 2026
Lots 2see the lot list below
Contract term 2 yrsends 31 Mar 2029 · up to 31 Mar 2031 with extensions · starts 1 Apr 2027

What is being bought2 lots · detail below

Published requirement description

The provision of Bacillus Calmette-Guérin (BCG) vaccine and intradermal diagnostic skin test for the detection of Mycobacterium tuberculosis infection. Deliveries will be required up to a period of 2 years, with an option to extend for up to an additional 24 months.

Information about volumes for each lot is included in the Invitation to Offer documents.

  • The authority expects to re-tender this requirement around 20 Oct 2026, 23:59 BST.
  • How the procedure runs: This procurement is conducted in accordance with the Procurement Act 2023 using a competitive flexible procedure. Initial Offers will be evaluated by the Authority against the award criteria set out in the Invitation to Offer. • Lot 1: Offerors for Lot 1 who pass the award criteria will proceed to the negotiation stage if a negotiation stage is required. A negotiation stage will be used for Lot 1 if any elements of the Offer are unclear or do not meet the Specification or otherwise require discussion using the subjects for negotiation set out • Lot 2: Offerors who pass the award criteria outlined will proceed to the negotiation stage for Lot 2. The Authority may choose to negotiate different aspects of the Offers with different Offerors, provided that the Authority does so in a manner consistent with the principles set out in section 12 of the Procurement Act 2023, including the duty to act transparently and to treat suppliers fairly. After the Negotiation Stage has closed, the Authority will invite final Offers in the form of a resubmission. Further information on the negotiation process is described in the tender documentation.

CPV: Diagnostic agents · Vaccines

Lots and requirements (2)Procurement structure

2 lots · all with a published value
Lot #1Bacillus Calmette-Guérin (BCG) vaccineRenewal 2 yrsPublished value£0

BCG vaccine indicated for the prevention of Tuberculosis

Contract period: 1 Apr 2027 – 31 Mar 2029 (2 yrs) · up to 31 Mar 2031 with extensions
Delivery: UK
Extensions: There is an option for the Authority to extend for a period or periods up to an additional 24 months
Lot #2Intradermal diagnostic skin test for the detection of Mycobacterium tuberculosisRenewal 2 yrsPublished value£0

An intradermal diagnostic skin test, indicated for the detection of Mycobacterium tuberculosis infection

Contract period: 1 Apr 2027 – 31 Mar 2029 (2 yrs) · up to 31 Mar 2031 with extensions
Delivery: UK
Extensions: There is an option for the Authority to extend for a period or periods up to an additional 24 months

Procedure terms & legal framework

From the official record
Procedure method
Competitive flexible procedure
Legal basis
UKPGA · 2023/54 Procurement Act 2023
Procurement category
Goods
Notice status
Closed
Procurement threshold
Above threshold (FTS publication)
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Competitive procedure
GPA / WTO covered
Unspecified in notice
Recurring procurement
Yes · next expected 20 Oct 2026
First published
29 Apr 2026, 12:21 BST
Last source update
11 May 2026, 13:48 BST
Award evaluation window
Submission end – 20 Oct 2026
Authority reference
C426981
FTS notice number
2026/S 000-043013
Latest notice
Tender notice (UK4)
Classification (CPV)
Diagnostic agentsVaccines
Delivery area
UK
Official registry OCID
ocds-h6vhtk-068de0 Find a Tender
How it runs

This procurement is conducted in accordance with the Procurement Act 2023 using a competitive flexible procedure.

Initial Offers will be evaluated by the Authority against the award criteria set out in the Invitation to Offer.

  • Lot 1: Offerors for Lot 1 who pass the award criteria will proceed to the negotiation stage if a negotiation stage is required. A negotiation stage will be used for Lot 1 if any elements of the Offer are unclear or do not meet the Specification or otherwise require discussion using the subjects for negotiation set out
  • Lot 2: Offerors who pass the award criteria outlined will proceed to the negotiation stage for Lot 2.

The Authority may choose to negotiate different aspects of the Offers with different Offerors, provided that the Authority does so in a manner consistent with the principles set out in section 12 of the Procurement Act 2023, including the duty to act transparently and to treat suppliers fairly.

After the Negotiation Stage has closed, the Authority will invite final Offers in the form of a resubmission.

Further information on the negotiation process is described in the tender documentation.

Review and risk notes
Risks

The below known unknown risks has been identified, which may require modification of the contract under paragraph 5 of Schedule 8 to the PA 2023 if one of the below identified risks materialise.

Risk 1:

The COVID-19 pandemic led to lockdown events, which disrupted the distribution and uptake of some national immunisation campaigns. The forecast delivery and stock requirements were substantially changed as a result. An ongoing risk is the materialisation of a UK health emergency or global pandemic, which may materialise in any given year.

How the risk may impact on the performance of the contract:

A health emergency or pandemic may materially affect the uptake of the product(s). Continued delivery of the product(s) within the original term of the contract could jeopardise stock management and effective use of product before expiry.

Why is it not possible to address the potential impact of such risks?

UKHSA and suppliers cannot reasonably predict the occurrence of a pandemic. UKHSA cannot determine an effective delivery schedule and contract term which would be effective during a pandemic to mitigate the risk of reduced uptake.

How it was run

Official notice
Run through: Atamis legacy domain (health-family.force.com) · Who buys & how to bid on Atamis
Supplier login requiredElectronic submission allowedLanguage: EN
Access & registration note: Legacy Salesforce domain still used in notices — use the current Atamis portal · this portal address is a legacy domain; the operator has migrated
Submission deadline
15 Jun 2026, 13:00 BST
Clarification deadline
1 Jun 2026, 13:00 BST
Submission channel
Official e-sourcing portal
Electronic submission
Allowed
Accepted languages
en
Detailed submission instructions & authority contactsFrom official release

Timeline

29 Apr 2026 → 1 Apr 2027 · 7 dates
  1. Planning notice published182 days ago
    29 Apr 2026, 12:21 BST
  2. Next notice expected174 days ago
    6 May 2026, 23:59 BST
  3. Tender notice published170 days ago
    11 May 2026, 13:48 BST
  4. Clarification questions by149 days ago
    1 Jun 2026, 13:00 BST
  5. Submission deadline135 days ago
    15 Jun 2026, 13:00 BST
  6. Award decision expected by7 days ago
    20 Oct 2026, 23:59 BST
  7. Today
    28 Oct 2026
  8. Contract startsin 154 days
    1 Apr 2027, 00:00 BST

Notice history

5 events · 2 releases on Find a Tender · since 29 Apr 2026
  1. Preliminary market engagement notice published
    29 Apr 2026, 12:21 BST
    UK2
  2. Tender notice published
    11 May 2026, 13:48 BST
    UK4
  3. Status changed to active
    11 May 2026, 13:48 BST
  4. Procurement method changed
    11 May 2026, 13:48 BST
  5. Deadline published: 15 Jun 2026, 13:00 BST
    11 May 2026, 13:48 BST

Contracting authority & participating public bodies

Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency

Contracting authorityPublic authority - central government GB-PPON: PBMQ-7576-DVGW 10 South Colonnade, London, London, E14 4PUContact name, email

Official documents & specifications (2)

Official links; attachments are not copied

Notices published for this procedure